RASD1
Dexamethasone-induced Ras-related protein 1
Also known as: AGS1, DEXRAS1, RASD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y272
- Gene
- RASD1
- Ensembl
- ENSG00000108551
- Chromosome
- 17
- Canonical length
- 281 aa
- Protein class
- Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane
OverviewNCBI Gene
This gene encodes a member of the Ras superfamily of small GTPases and is induced by dexamethasone. The encoded protein is an activator of G-protein signaling and acts as a direct nucleotide exchange factor for Gi-Go proteins. This protein interacts with the neuronal nitric oxide adaptor protein CAPON, and a nuclear adaptor protein FE65, which interacts with the Alzheimer's disease amyloid precursor protein. This gene may play a role in dexamethasone-induced alterations in cell morphology, growth and cell-extracellular matrix interactions. Epigenetic inactivation of this gene is closely correlated with resistance to dexamethasone in multiple myeloma cells. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
281 residues, UniProt reviewed canonical sequence.
>Q9Y272|RASD1
1 MKLAAMIKKM CPSDSELSIP AKNCYRMVIL GSSKVGKTAI VSRFLTGRFE DAYTPTIEDF
61 HRKFYSIRGE VYQLDILDTS GNHPFPAMRR LSILTGDVFI LVFSLDNRDS FEEVQRLRQQ
121 ILDTKSCLKN KTKENVDVPL VICGNKGDRD FYREVDQREI EQLVGDDPQR CAYFEISAKK
181 NSSLDQMFRA LFAMAKLPSE MSPDLHRKVS VQYCDVLHKK ALRNKKLLRA GSGGGGGDPG
241 DAFGIVAPFA RRPSVHSDLM YIREKASAGS QAKDKERCVI SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RASD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 352 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 352 nTPM
- liver: 244 nTPM
- adipose tissue: 233 nTPM
- skeletal muscle: 171 nTPM
- kidney: 156 nTPM
- breast: 148 nTPM
Single-cell type
- endometrial glandular cells: 456 nCPM
- endometrial luminal cells: 436 nCPM
- peritubular myoid cells: 417 nCPM
- müller glia: 391 nCPM
- goblet cells: 258 nCPM
- myosatellite cells: 253 nCPM
Immune cell
- plasmacytoid DC: 160 nTPM
- intermediate monocyte: 3.5 nTPM
- total PBMC: 1 nTPM
- non-classical monocyte: 0.8 nTPM
- classical monocyte: 0.4 nTPM
- gdT-cell: 0.4 nTPM
Brain region
- medulla oblongata: 135 nTPM
- cerebral cortex: 124 nTPM
- hypothalamus: 115 nTPM
- basal ganglia: 114 nTPM
- white matter: 92 nTPM
- midbrain: 89 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.18
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.37
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled receptor signaling pathway
- negative regulation of DNA-templated transcription
- nitric oxide mediated signal transduction
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RASD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RASD1 as an antibody target. Whether an autoantibody or antibody against RASD1 could matter depends on whether native RASD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RASD1 is annotated at the cell surface, where native RASD1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RASD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...